Sponsor content
65 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ERLOTINIB CIPLA erlotinib (as hydrochloride) 25 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLOTINIB erlotinib (as hydrochloride) 25 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEFERACIP deferasirox 360 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESIROX deferasirox 180 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEFERACIP deferasirox 90 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEFERACIP deferasirox 180 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESIROX deferasirox 90 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESIROX deferasirox 360 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA PAIN RELIEF PARACETAMOL 500 + CODEINE 9.6 paracetamol 500 mg and codeine phosphate hemihydrate 9.6 mg tablet blister pack.
-
Prescription medicine decision summaryTGA decision: Bevacip/Bevaciptin (bevacizumab) is approved to treat various types of cancers.